Ripple Therapeutics announced today that it entered into a deal with a Bausch + Lomb affiliate related to drug delivery technology. Toronto-based Ripple develops a patented technology platform based on drugs chemically engineered into controlled-release pharmaceuticals without the use of polymers. The proprietary prodrugs undergo surface erosion to give zero-order release kinetics. They are highly […]
